These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 21351377)

  • 21. Lipid abnormalities and cardiovascular risk in renal disease.
    Ritz E; Wanner C
    J Am Soc Nephrol; 2008 Jun; 19(6):1065-70. PubMed ID: 18369085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Statins in chronic renal disease].
    Ferreira SR; Rocha AM; Saraiva JF
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():45-9. PubMed ID: 16400399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [On behalf and the extent of evidence].
    Ruiz J
    Rev Med Suisse; 2010 Jun; 6(252):1171-2. PubMed ID: 20614750
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
    Jones PH
    Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Chronic kidney disease and statins].
    Matovinović MS
    Lijec Vjesn; 2006; 128(11-12):345-50. PubMed ID: 17212196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is it time to stop treating dyslipidaemia with fibrates?
    Benatar JR; Stewart RA
    N Z Med J; 2007 Sep; 120(1261):U2706. PubMed ID: 17853928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Jupiter study, CRP screening, and aggressive statin therapy-implications for the primary prevention of cardiovascular disease.
    Kones R
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):309-15. PubMed ID: 19460829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: a role for combination fibrate therapy.
    Fazio S
    Clin Ther; 2008 Feb; 30(2):294-306. PubMed ID: 18343268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [JUPITER study, more reason to give statins as preventive measure - commentary].
    Narkiewicz K
    Kardiol Pol; 2009 Mar; 67(3):346-7. PubMed ID: 19469067
    [No Abstract]   [Full Text] [Related]  

  • 30. Most would fail to benefit from JUPITER Intervention.
    Plonk WM
    J Am Coll Cardiol; 2009 Aug; 54(8):744; author reply 744-5. PubMed ID: 19679258
    [No Abstract]   [Full Text] [Related]  

  • 31. Reinitiation of statins after statin-associated musculoskeletal symptoms: a patient-centered approach.
    Brito JP; Montori VM
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):243-7. PubMed ID: 23481527
    [No Abstract]   [Full Text] [Related]  

  • 32. Are statins effective in high-risk primary prevention?
    Dentali F; Guasti L
    Arch Intern Med; 2010 Dec; 170(22):2042-3; author reply 2043-4. PubMed ID: 21149769
    [No Abstract]   [Full Text] [Related]  

  • 33. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU; Watson K; Knopp RH
    J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract]   [Full Text] [Related]  

  • 34. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 35. Cardiovascular risk reduction: what do recent trials with rosuvastatin tell us?
    Fabbri G; Maggioni AP
    Adv Ther; 2009 May; 26(5):469-87. PubMed ID: 19444394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. JUPITER "moderate CKD" subgroup is not truly "moderate" chronic kidney disease.
    Roberts MA; Hare DL
    J Am Coll Cardiol; 2010 Aug; 56(6):528; author reply 530. PubMed ID: 20670769
    [No Abstract]   [Full Text] [Related]  

  • 37. Statin Intolerance From a Clinician's Perspective.
    Whayne TF
    Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
    [No Abstract]   [Full Text] [Related]  

  • 38. Primary prevention: dyslipidaemia.
    Pignone M
    Clin Evid; 2005 Dec; (14):142-50. PubMed ID: 16620402
    [No Abstract]   [Full Text] [Related]  

  • 39. Statin therapy in patients with type 2 diabetes.
    Lo V; Noviasky J; Nashelsky J
    Am Fam Physician; 2005 Sep; 72(5):866-8. PubMed ID: 16156346
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiometabolic risk-factor management.
    Ker J
    Cardiovasc J Afr; 2008; 19(4):222-4. PubMed ID: 18776972
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.